LNTH Q2 2017 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

Q2 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$89M+13.9% YoY

Gross Profit

$46M51.7% margin

Operating Income

$18M20.1% margin

Net Income

$14M15.3% margin

EPS (Diluted)

$0.35

QoQ Revenue Growth

+9.2%

Cash Flow

Operating Cash Flow

$21M

Free Cash Flow

$17M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$268M

Total Liabilities

$355M

Stockholders' Equity

-$87M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$89M	$78M	+13.9%
Gross Profit	$46M	$36M	+28.5%
Operating Income	$18M	$14M	+26.2%
Net Income	$14M	$7M	+85.0%

Revenue Segments

US Segment

$78M88%

International Segment

$11M12%